1. Home
  2. MIRM vs CARG Comparison

MIRM vs CARG Comparison

Compare MIRM & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRM
  • CARG
  • Stock Information
  • Founded
  • MIRM 2018
  • CARG 2005
  • Country
  • MIRM United States
  • CARG United States
  • Employees
  • MIRM 349
  • CARG N/A
  • Industry
  • MIRM Biotechnology: Pharmaceutical Preparations
  • CARG EDP Services
  • Sector
  • MIRM Health Care
  • CARG Technology
  • Exchange
  • MIRM Nasdaq
  • CARG Nasdaq
  • Market Cap
  • MIRM 3.7B
  • CARG 3.2B
  • IPO Year
  • MIRM 2019
  • CARG 2017
  • Fundamental
  • Price
  • MIRM $72.85
  • CARG $34.78
  • Analyst Decision
  • MIRM Strong Buy
  • CARG Buy
  • Analyst Count
  • MIRM 11
  • CARG 13
  • Target Price
  • MIRM $76.09
  • CARG $38.42
  • AVG Volume (30 Days)
  • MIRM 712.9K
  • CARG 1.1M
  • Earning Date
  • MIRM 11-11-2025
  • CARG 11-06-2025
  • Dividend Yield
  • MIRM N/A
  • CARG N/A
  • EPS Growth
  • MIRM N/A
  • CARG N/A
  • EPS
  • MIRM N/A
  • CARG 1.24
  • Revenue
  • MIRM $429,161,000.00
  • CARG $919,087,000.00
  • Revenue This Year
  • MIRM $53.14
  • CARG $6.25
  • Revenue Next Year
  • MIRM $19.83
  • CARG $5.86
  • P/E Ratio
  • MIRM N/A
  • CARG $28.02
  • Revenue Growth
  • MIRM 62.33
  • CARG 4.79
  • 52 Week Low
  • MIRM $36.88
  • CARG $24.65
  • 52 Week High
  • MIRM $78.10
  • CARG $41.33
  • Technical
  • Relative Strength Index (RSI)
  • MIRM 56.46
  • CARG 42.99
  • Support Level
  • MIRM $70.49
  • CARG $36.62
  • Resistance Level
  • MIRM $74.96
  • CARG $38.62
  • Average True Range (ATR)
  • MIRM 1.82
  • CARG 0.95
  • MACD
  • MIRM -0.72
  • CARG -0.36
  • Stochastic Oscillator
  • MIRM 51.03
  • CARG 6.32

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

Share on Social Networks: